Company Filing History:
Years Active: 2022
Title: Kazuhiko Ishikawa: Innovator in Reverse Transcriptase Technology
Introduction
Kazuhiko Ishikawa is a prominent inventor based in Sakai, Japan. He is known for his significant contributions to the field of molecular biology, particularly in the development of heat-resistant reverse transcriptase mutants. His work has implications for various applications in genetic research and biotechnology.
Latest Patents
Kazuhiko Ishikawa holds a patent for a heat-resistant reverse transcriptase mutant. This invention includes a reverse transcriptase mutant characterized by an amino acid mutation at a position corresponding to position 55 of the amino acid sequence of wild-type reverse transcriptase derived from the Moloney murine leukemia virus. The mutant is defined by a substitution from threonine to another amino acid, selected from a group consisting of amino acids with nonpolar aliphatic side chains and polar acidic functional group side chains. The patent also encompasses a nucleic acid that encodes the mutant, methods for producing the mutant and the nucleic acid, a method for synthesizing cDNA using the mutant, and a composition and kit that includes the mutant.
Career Highlights
Kazuhiko Ishikawa is associated with Takara Bio Inc., a company that specializes in biotechnology and molecular biology products. His work at Takara Bio Inc. has allowed him to focus on innovative solutions that advance the field of genetic research.
Collaborations
Kazuhiko has collaborated with notable colleagues, including Takashi Uemori and Nariaki Takatsu. These collaborations have contributed to the advancement of research and development in their respective fields.
Conclusion
Kazuhiko Ishikawa's contributions to the field of reverse transcriptase technology highlight his innovative spirit and dedication to scientific advancement. His patent for a heat-resistant reverse transcriptase mutant represents a significant step forward in molecular biology.